Green Thumb Industries (GTBIF) Cash from Investing Activities (2019 - 2026)

Green Thumb Industries (GTBIF) posted Cash from Investing Activities of -$20.6 million for Q1 2026, down 7.44% on a QoQ basis from -$19.2 million in Q4 2025, and up 32.69% year-over-year from -$15.5 million in Q1 2025.

Green Thumb Industries (GTBIF) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Green Thumb Industries' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$20.6 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 32.69% year-over-year to -$20.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$120.4 million (down 9.61% YoY) and the FY2025 annual result came in at -$130.4 million, down 45.63% from the prior year.
  • Cash from Investing Activities was -$20.6 million for Q1 2026 at Green Thumb Industries, down from -$19.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$10.3 million in Q1 2024 and bottomed at -$100.4 million in Q1 2022.
  • A 5-year average of -$40.5 million and a median of -$36.1 million in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 1286.56% — and 2024, when it surged 84.65%.
  • Green Thumb Industries' Cash from Investing Activities stood at -$58.8 million in 2022, then surged by 31.16% to -$40.5 million in 2023, then climbed by 10.78% to -$36.1 million in 2024, then surged by 46.95% to -$19.2 million in 2025, then retreated by 7.44% to -$20.6 million in 2026.
  • Business Quant data shows GTBIF's Cash from Investing Activities at -$20.6 million in Q1 2026, -$19.2 million in Q4 2025, and -$13.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Green Thumb Industries 1.63 Bn 1.29 Bn 143.65 Mn -20.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -20.58 Mn
Mar 31, 2026 -20.58 Mn
Dec 31, 2025 -19.15 Mn
Dec 31, 2025 -19.15 Mn
Sep 30, 2025 -13.00 Mn
Sep 30, 2025 -13.00 Mn
Jun 30, 2025 -67.67 Mn
Jun 30, 2025 -67.67 Mn
Mar 31, 2025 -30.57 Mn
Mar 31, 2025 -30.57 Mn
Dec 31, 2024 -36.10 Mn
Dec 31, 2024 -36.10 Mn
Sep 30, 2024 -19.11 Mn
Sep 30, 2024 -19.11 Mn
Jun 30, 2024 -24.06 Mn
Jun 30, 2024 -24.06 Mn
Mar 31, 2024 -10.27 Mn
Mar 31, 2024 -10.27 Mn
Dec 31, 2023 -40.46 Mn
Dec 31, 2023 -40.46 Mn